METHOCARBAMOL Drug Patent Profile
✉ Email this page to a colleague
When do Methocarbamol patents expire, and what generic alternatives are available?
Methocarbamol is a drug marketed by Dr Reddys, Marsam Pharms Llc, Am Regent, Baxter Hlthcare Corp, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Monterey Pharms Llc, Navinta Llc, Norvium Bioscience, Sagent Pharms Inc, Slate Run Pharma, Somerset Theraps Llc, Able, Allied, Am Therap, Ani Pharms, Ascot, Aurobindo Pharma Ltd, Beximco Pharms Usa, Chartwell Molecular, Clonmel Hlthcare, Fosun Pharma, Granules, Hangzhou Binjiang, Heather, Hetero Labs Ltd Iii, Hikma Intl Pharms, Hlthcare, Impax Labs, Inwood Labs, Ivax Sub Teva Pharms, Kv Pharm, Mikart, Mylan, Nylos, Oxford Pharms, Pioneer Pharms, Prinston Inc, Puracap Pharm, Purepac Pharm, Roxane, Sandoz, Solvay, Sun Pharm Industries, Superpharm, Tablicaps, Upsher Smith, Watson Labs, Mcneil, Par Pharm, and Stevens J. and is included in seventy-four NDAs.
The generic ingredient in METHOCARBAMOL is aspirin; methocarbamol. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; methocarbamol profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METHOCARBAMOL?
- What are the global sales for METHOCARBAMOL?
- What is Average Wholesale Price for METHOCARBAMOL?
Summary for METHOCARBAMOL
| US Patents: | 0 |
| Applicants: | 52 |
| NDAs: | 74 |
| Finished Product Suppliers / Packagers: | 61 |
| Raw Ingredient (Bulk) Api Vendors: | 105 |
| Clinical Trials: | 10 |
| Patent Applications: | 3,585 |
| Drug Prices: | Drug price information for METHOCARBAMOL |
| Drug Sales Revenues: | Drug sales revenues for METHOCARBAMOL |
| DailyMed Link: | METHOCARBAMOL at DailyMed |
See drug prices for METHOCARBAMOL
Recent Clinical Trials for METHOCARBAMOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Allucent | Phase 3 |
| Arthritis Innovation Corporation | Phase 3 |
| Prisma Health-Upstate | Phase 4 |
Pharmacology for METHOCARBAMOL
| Drug Class | Muscle Relaxant |
| Physiological Effect | Centrally-mediated Muscle Relaxation |
Medical Subject Heading (MeSH) Categories for METHOCARBAMOL
Anatomical Therapeutic Chemical (ATC) Classes for METHOCARBAMOL
US Patents and Regulatory Information for METHOCARBAMOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solvay | METHOCARBAMOL | methocarbamol | TABLET;ORAL | 084448-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hetero Labs Ltd Iii | METHOCARBAMOL | methocarbamol | TABLET;ORAL | 090200-001 | Nov 6, 2009 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fosun Pharma | METHOCARBAMOL | methocarbamol | TABLET;ORAL | 084616-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mcneil | METHOCARBAMOL AND ASPIRIN | aspirin; methocarbamol | TABLET;ORAL | 089193-001 | Feb 12, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Inwood Labs | METHOCARBAMOL | methocarbamol | TABLET;ORAL | 085137-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
